Tejas Patil (T Patil)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Tyrosine Kinase

Neoadjuvant Chemotherapy

Top Venues

NPJ precision oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Luke R G Pike, Emily Miao, Lillian A Boe, Tejas Patil, Brandon S Imber, Nathaniel J Myall, Erqi L Pollom, Caressa Hui, Vera Qu, Jacob Langston, Veronica L Chiang, Michael Grant, Sarah B Goldberg, Joshua David Palmer, Rahul N Prasad, Tony J C Wang, Albert Lee, Catherine A Shu, Lanyi Nora Chen, Nicholas J Thomas, Steve E Braunstein, Brian D Kavanagh, D Ross Camidge, Chad G Rusthoven
Tyrosine Kinase Inhibitors With and Without Up-Front Stereotactic Radiosurgery for Brain Metastases From EGFR and ALK Oncogene-Driven Non-Small Cell Lung Cancer (TURBO-NSCLC). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Collin M Blakely, Anatoly Urisman, Matthew A Gubens, Claire K Mulvey, Greg M Allen, Stephen C Shiboski, Julia K Rotow, Turja Chakrabarti, D Lucas Kerr, Jacqueline V Aredo, Bianca Bacaltos, Megan Gee, Lisa Tan, Kirk D Jones, W Patrick Devine, Robert C Doebele, Dara L Aisner, Tejas Patil, Erin L Schenk, Trever G Bivona, Jonathan W Riess, Melissa Coleman, Johannes R Kratz, David M Jablons
Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Phase II Multicenter Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Collin M Blakely, Anatoly Urisman, Matthew A Gubens, Claire K Mulvey, Greg M Allen, Stephen C Shiboski, Julia K Rotow, Turja Chakrabarti, D Lucas Kerr, Jacqueline V Aredo, Bianca Bacaltos, Megan Gee, Lisa Tan, Kirk D Jones, W Patrick Devine, Robert C Doebele, Dara L Aisner, Tejas Patil, Erin L Schenk, Trever G Bivona, Jonathan W Riess, Melissa Coleman, Johannes R Kratz, David M Jablons
Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Phase II Multicenter Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Emily K Kleczko, Trista K Hinz, Teresa T Nguyen, Natalia J Gurule, Andre Navarro, Anh T Le, Amber M Johnson, Jeff Kwak, Diana I Polhac, Eric T Clambey, Mary Weiser-Evans, Daniel T Merrick, Michael C Yang, Tejas Patil, Erin L Schenk, Lynn E Heasley, Raphael A Nemenoff
Durable responses to alectinib in murine models of EML4-ALK lung cancer requires adaptive immunity. NPJ precision oncology 7 (1) (2023)
Michael J Grant, Jacqueline V Aredo, Jacqueline H Starrett, Paul Stockhammer, Iris K van Alderwerelt van Rosenburgh, Anna Wurtz, Andrew J Piper-Vallillo, Zofia Piotrowska, Christina J Falcon, Helena Alexandra Yu, Charu Aggarwal, Dylan G Scholes, Tejas Patil, Christina Nguyen, Manali Phadke, Fang-Yong Li, Joel W Neal, Mark A Lemmon, Zenta Walther, Katerina Politi, Sarah B Goldberg
Efficacy of osimertinib in patients with lung cancer positive for uncommon EGFR exon 19 deletion mutations. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Emily K Kleczko, Trista K Hinz, Teresa T Nguyen, Natalia J Gurule, Andre Navarro, Anh T Le, Amber M Johnson, Jeff Kwak, Diana I Polhac, Eric T Clambey, Mary Weiser-Evans, Daniel T Merrick, Michael C Yang, Tejas Patil, Erin L Schenk, Lynn E Heasley, Raphael A Nemenoff
Durable responses to alectinib in murine models of EML4-ALK lung cancer requires adaptive immunity. NPJ precision oncology 7 (1) (2023)
Mandy Sakamoto, Tejas Patil
Exceptional response to lorlatinib and cabozantinib in ROS1-rearranged NSCLC with acquired F2004V and L2086F resistance. NPJ precision oncology 7 (1) (2023)
Emily K Kleczko, Trista K Hinz, Teresa T Nguyen, Natalia J Gurule, Andre Navarro, Anh T Le, Amber M Johnson, Jeff Kwak, Diana I Polhac, Eric T Clambey, Mary Weiser-Evans, Daniel T Merrick, Michael C Yang, Tejas Patil, Erin L Schenk, Lynn E Heasley, Raphael A Nemenoff
Durable responses to alectinib in murine models of EML4-ALK lung cancer requires adaptive immunity. NPJ precision oncology 7 (1) (2023)
Tejas Patil, Paul A Bunn
Adjuvant Osimertinib in EGFR-Mutant Early-Stage NSCLC: Does HRQoL Influence Decisions? Clinical cancer research : an official journal of the American Association for Cancer Research 28 (11) (2022)
Natalia J Gurule, Caroline E McCoach, Trista K Hinz, Daniel T Merrick, Adriaan Van Bokhoven, Jihye Kim, Tejas Patil, Jacob Calhoun, Raphael A Nemenoff, Aik Choon Tan, Robert C Doebele, Lynn E Heasley
A tyrosine kinase inhibitor-induced interferon response positively associates with clinical response in EGFR-mutant lung cancer. NPJ precision oncology 5 (1) (2021)
T L Peters, Tejas Patil, A T Le, K D Davies, P M Brzeskiewicz, H Nijmeh, L Bao, D R Camidge, D L Aisner, Robert C Doebele
Evolution of MET and NRAS gene amplification as acquired resistance mechanisms in EGFR mutant NSCLC. NPJ precision oncology 5 (1) (2021)